Do neutrophil/lymphocyte, monocyte/lymphocyte, platelet/lymphocyte ratios affect prognosis and stage in avascular necrosis of the femoral head?

被引:0
|
作者
Gokalp, Alp Yekta [1 ]
Tekin, Sezgin Bahadir [2 ,3 ]
机构
[1] Adiyaman Golbasi State Hosp, Dept Psychiat, Gaziantep, Turkiye
[2] Gaziantep Univ, Dept Orthoped Surg, Gaziantep, Turkiye
[3] Bestepe Mahallesi 192091 Nolu Sokak H11b-17,Sahinb, Gaziantep, Turkiye
关键词
Femur avascular necrosis; NLR; PLR; MLR; Ficat-Arlet; LYMPHOCYTE RATIO; MONOCYTE RATIO; NEUTROPHIL; PREDICTOR; PLATELET; RISK;
D O I
10.4149/BLL_2024_59
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION: Avascular necrosis of the femoral head (AVNFH) is an osteonecrosis type caused by ischaemic osteocyte loss of femoral head, and its exact pathomechanism is still unknown. Neutrophil, lymphocyte, monocyte, platelet levels in complete blood count and ratios between these levels have been used by almost all medical disciplines as accesible and reliable biomarkers of immune response. Aim of this study is to identify the effects of neutrophil/lymphocyte (NL), monocyte/lymphocyte (ML), platelet/lymphocyte (PLT/L) ratios on prognosis and stage in patients with avascular necrosis of the femoral head (AVNFH). MATERIALS AND METHODS: A total of 106 (30 female; 76 male) patients aged 18 and over diagnosed with avascular necrosis of femoral head between 2012-2022 years were retrospectively evaluated. Study was planned after a total of 106 (30 female, 76 male) healthy patients with consent to participate who were demographically equal to the study group were included in the control group. Patients in the study group were divided into 3 groups as Stage I, II and III according to the Ficat-Arlet classification. RESULTS: In terms of neutrophil counts; neutrophil values of study and control groups were 4.94 +/- 1.89 and 4,21 +/- 1,17; respectively. There was statistically significant difference between counts (p<0.05). In terms of neutrophil/lymphocyte ratio, NL ratio was statistically significantly higher in study group (2.11 +/- 0.85) than control group (1.75 +/- 0.44). Cut-off value of NL ratio was 2.13 according to the ROC analysis (sensitivity 47.17% (95% CI (37.4-57.1)); specificity=84.91% 95% GA (76.6-91.1)). Sensitivity and specificity of cut-off value was statistically significant. There was no difference between groups created according to Ficat-Arlet in terms of hemogram parameters. DISCUSSION: NL may indicate AVNFH; however, other parameters are considered as inadequate for identifying an independent marker in AVNFH due to ineffective immune response. Future studies with larger samples which allow standard and multi -dimensional analysis are needed (Tab. 4, Fig. 5, Ref. 20) . Text in PDF www.elis.sk
引用
收藏
页码:387 / 391
页数:5
相关论文
共 50 条
  • [1] Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in schizophrenia
    Zhu, Xiaoyu
    Zhou, Jia
    Zhu, Yu
    Yan, Feng
    Han, Xiaole
    Tan, Yunlong
    Li, Ran
    AUSTRALASIAN PSYCHIATRY, 2022, 30 (01) : 95 - 99
  • [2] Neutrophil/Lymphocyte, Platelet/Lymphocyte, and Monocyte/Lymphocyte Ratios in Mood Disorders
    Marazziti, Donatella
    Torrigiani, Samuele
    Carbone, Manuel G.
    Mucci, Federico
    Flamini, Walter
    Ivaldi, Tea
    Dell'Osso, Liliana
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (36) : 5758 - 5781
  • [3] Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in patients with affective disorders
    Wei, Yanyan
    Feng, Junhui
    Ma, Jinbao
    Chen, Dongning
    Chen, Jingxu
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 309 : 221 - 228
  • [4] Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in different stages of schizophrenia
    Ozdin, Selcuk
    Boke, Omer
    PSYCHIATRY RESEARCH, 2019, 271 : 131 - 135
  • [5] Evaluation of Plateletcrit and Neutrophil/Lymphocyte, Monocyte/Lymphocyte and Platelet/Lymphocyte Ratios in Endometrial Polyp
    Cakir, Anil Turhan
    Oz, Isa Sukru
    ISTANBUL MEDICAL JOURNAL, 2020, 21 (05): : 362 - 365
  • [6] Evaluation of Monocyte/Lymphocyte, Neutrophil/Lymphocyte, and Platelet/Lymphocyte Ratios in Patients with Temporal Lobe
    Bolayir, Asli
    ARCHIVES OF EPILEPSY, 2022, 28 (01): : 29 - 34
  • [7] Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients
    B. Losada
    J. A. Guerra
    D. Malón
    C. Jara
    L. Rodriguez
    S. Del Barco
    Clinical and Translational Oncology, 2019, 21 : 855 - 863
  • [8] Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients
    Losada, B.
    Guerra, J. A.
    Malon, D.
    Jara, C.
    Rodriguez, L.
    Del Barco, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (07): : 855 - 863
  • [9] Platelet/lymphocyte, neutrophil/lymphocyte, and lymphocyte/monocyte ratios as biomarkers for rheumatoid arthritis: correlation with disease activity
    Sahar A. Elsayed
    Shereen M. Basily
    Mohamed A. Esmail
    Ola Mounir
    Egyptian Rheumatology and Rehabilitation, 50
  • [10] Platelet/lymphocyte, neutrophil/lymphocyte, and lymphocyte/monocyte ratios as biomarkers for rheumatoid arthritis: correlation with disease activity
    Elsayed, Sahar A.
    Basily, Shereen M.
    Esmail, Mohamed A.
    Mounir, Ola
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2023, 50 (01)